Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
株式のランク #27702
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
株価
$2.18
時価総額
$31.27M
変化(1日)
2.27%
変化(1年)
-61.30%
KR
取引 IMBdx (461030)

カテゴリー

IMBdx(461030)の株価履歴
終値の最高値: $2.31 (2026-08-01)

終値の最安値: $14.99 (2024-04-01)
IMBdx の株価履歴(2024 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -26.19%
2025 -3.47%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$753.28 5.84%
CH